Moreover, plasma LDHA, CCL2, and CCL7 levels were not related to the status of recurrence, gender, age, and MGMT methylation in glioblastoma patients (Supplementary Fig. S16a–l). The gene discussed is CCL2; the disease is glioblastoma.